HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gilles Freyer Selected Research

Capecitabine (Xeloda)

1/2018Over-adherence to capecitabine: a potential safety issue in breast and colorectal cancer patients.
7/2015Adherence to oral anticancer chemotherapy: What influences patients' over or non-adherence? Analysis of the OCTO study through quantitative-qualitative methods.
1/2011Current targeted therapies in breast cancer: clinical applications in the elderly woman.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gilles Freyer Research Topics

Disease

33Neoplasms (Cancer)
01/2022 - 01/2003
14Breast Neoplasms (Breast Cancer)
09/2021 - 01/2002
13Ovarian Neoplasms (Ovarian Cancer)
06/2021 - 05/2011
6Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 05/2002
5Disease Progression
01/2022 - 03/2012
5Carcinoma (Carcinomatosis)
01/2022 - 05/2012
5Prostatic Neoplasms (Prostate Cancer)
11/2021 - 04/2003
3Ovarian Epithelial Carcinoma
01/2018 - 01/2015
3Neoplasm Metastasis (Metastasis)
01/2018 - 04/2003
3Graft vs Host Disease (Graft-Versus-Host Disease)
03/2011 - 01/2007
2Neutropenia
01/2022 - 01/2013
2Circulating Neoplastic Cells
11/2021 - 01/2021
2Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational)
01/2020 - 01/2017
2Lung Neoplasms (Lung Cancer)
10/2017 - 06/2013
2Febrile Neutropenia
06/2016 - 10/2015
2Melanoma (Melanoma, Malignant)
11/2014 - 06/2013
2Endometrial Neoplasms (Endometrial Cancer)
12/2013 - 04/2003
2Pathologic Complete Response
05/2012 - 04/2002
1Cicatrix (Scar)
11/2021
1COVID-19
10/2021
1Trophoblastic Neoplasms (Trophoblastic Tumor)
01/2020
1Transient Ischemic Attack
01/2019
1Thrombotic Microangiopathies
01/2018
1Constipation
11/2016
1Hypoalbuminemia
10/2016
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
06/2016
1Renal Cell Carcinoma (Grawitz Tumor)
05/2016
1Lymphoma (Lymphomas)
11/2015

Drug/Important Bio-Agent (IBA)

8PlatinumIBA
12/2021 - 01/2015
6Pharmaceutical PreparationsIBA
06/2017 - 02/2003
5Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2022 - 01/2013
5Hormones (Hormone)IBA
09/2021 - 04/2003
5Docetaxel (Taxotere)FDA Link
04/2016 - 01/2002
4Biomarkers (Surrogate Marker)IBA
11/2021 - 06/2013
3Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2022 - 11/2021
3Indicators and Reagents (Reagents)IBA
12/2021 - 06/2020
3Bevacizumab (Avastin)FDA Link
11/2021 - 01/2011
3Biological ProductsIBA
11/2021 - 11/2014
3Carboplatin (JM8)FDA LinkGeneric
06/2021 - 12/2015
3Paclitaxel (Taxol)FDA LinkGeneric
06/2021 - 01/2011
3Trastuzumab (Herceptin)FDA Link
01/2019 - 01/2011
3ErbB Receptors (EGF Receptor)IBA
01/2019 - 01/2011
3Capecitabine (Xeloda)FDA Link
01/2018 - 01/2011
3EverolimusFDA Link
01/2015 - 08/2012
3Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2014 - 05/2002
3Fluorouracil (Carac)FDA LinkGeneric
01/2011 - 05/2002
2Antineoplastic Agents (Antineoplastics)IBA
01/2022 - 02/2003
2Colony-Stimulating Factors (Colony Stimulating Factor)IBA
01/2022 - 01/2013
2Androgen Receptors (Androgen Receptor)IBA
11/2021 - 01/2021
2DNA (Deoxyribonucleic Acid)IBA
11/2021 - 10/2017
2Tumor Biomarkers (Tumor Markers)IBA
11/2021 - 12/2013
2Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
01/2020 - 01/2020
2Etoposide (VP 16)FDA LinkGeneric
11/2015 - 11/2008
2Sorafenib (BAY 43-9006)FDA Link
01/2015 - 02/2014
2Cyclosporine (Ciclosporin)FDA LinkGeneric
03/2011 - 12/2010
2Leucovorin (Folinic Acid)FDA Link
01/2011 - 05/2002
1eribulinFDA Link
01/2022
1Messenger RNA (mRNA)IBA
11/2021
1LigandsIBA
11/2021
1Oxygen (Dioxygen)IBA
10/2021
1enzalutamideIBA
01/2021
1abirateroneIBA
01/2021
1Methotrexate (Mexate)FDA LinkGeneric
01/2020
1avelumabIBA
01/2020
1Adenosine Diphosphate (ADP)IBA
12/2019
1Adenosine Diphosphate Ribose (ADP-Ribose)IBA
12/2019
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
12/2019
1niraparibIBA
12/2019
1TransferasesIBA
01/2019
1AntigensIBA
01/2019
1trebananibIBA
01/2019
1liposomal doxorubicin (Doxil)FDA Link
01/2019
1thiaclopridIBA
01/2019
1palbociclibIBA
01/2018
1Cell-Free Nucleic AcidsIBA
10/2017
1B7-H1 AntigenIBA
01/2017
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
10/2016
1Prostate-Specific Antigen (Semenogelase)IBA
06/2016
1Epirubicin (Ellence)FDA LinkGeneric
04/2016
1BI 6727IBA
03/2016
1Carmustine (FIVB)FDA Link
11/2015
1Cytarabine (Cytosar-U)FDA LinkGeneric
11/2015
1Melphalan (Alkeran)FDA LinkGeneric
11/2015

Therapy/Procedure

31Drug Therapy (Chemotherapy)
01/2022 - 01/2003
19Therapeutics
11/2021 - 01/2003
3Radiotherapy
01/2018 - 01/2003
2Castration
11/2021 - 01/2021
2Neoadjuvant Therapy
11/2021 - 01/2020
2Medication Errors (Medication Error)
01/2013 - 11/2011
2Drug Tapering
01/2013 - 02/2012
1Length of Stay
10/2021
1Adjuvant Chemotherapy
09/2021
1Molecular Targeted Therapy
10/2019
1Hyperthermic Intraperitoneal Chemotherapy
01/2018
1Curettage
01/2018
1Cytoreduction Surgical Procedures
01/2018
1Injections
06/2017
1Activities of Daily Living (ADL)
10/2016
1Aftercare (After-Treatment)
03/2016
1BEAM regimen
11/2015